Amy Peters received her doctoral degree in clinical psychology from the University of Illinois Chicago, where she specialized in lifespan neuropsychological assessment. She completed her predoctoral clinical internship within the University of Illinois Chicago College of Medicine and a two year post-doctoral clinical and research fellowship at the Massachusetts General Hospital (MGH) Psychology Assessment Center, which both focused on adult and geriatric assessment. She is currently a faculty member at MGH and Harvard Medical School, where she conducts research using neuroimaging to determine how immune dysregulation affects cognition and mood in psychiatric illness. This research is currently funded by the National Institute of Mental Health. Her clinical expertise includes neuropsychological assessment of adults with mild cognitive impairment or neurodegenerative conditions, acquired brain injuries, and other neurological conditions. She also assesses adults and adolescents with learning or intellectual disabilities, ADHD, concussion, or psychiatric illness. 

Amy Peters T32 experience:

Through my initial research, I was exposed to emerging research on the pathophysiology of depression and bipolar disorder, which suggests that chronic, low-grade systemic inflammation may cause changes in brain structure and function that predispose towards mood dysregulation. Accumulating evidence suggests a robust pro-inflammatory signature in adults with mood disorders, but it remains unclear whether inflammation is implicated in the pathophysiology of mood dysregulation among youth. I initiated collaboration with my research advisor, Dr. Amy West, and two other psychiatry faculty members, Dr. Scott Langenecker and Dr.Ghanshyam Pandey, who have expertise in neurocognitive mechanisms of mood disorders and biochemical
abnormalities associated with mood disorders and suicide, respectively. Our findings may help to discover new, more effective treatment pathways or repurpose existing intervention strategies for mood disorders, particularly among youth and adolescents who are at risk for severe illness trajectories.” I transitioned from pre-doctoral T32 support to a NIMH funded F31 NRSA fellowship; this application was submitted during my
year of T32 support and funded on the first round.